GPT and fatty liver disease: These findings suggest that although TMI alone may not be sufficient for MAFLD screening, its combination with metabolic indicators such as ALT, HOMA‐IR, and HDL‐C could increase its clinical relevance, particularly within a multi‐marker predictive model for hepatic steatosis in pediatric obesity.